# Flurazepam
*Source: https://go.drugbank.com/drugs/DB00690*

## Overview

### Description

This compound belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine.

### Background

A benzodiazepine derivative used mainly as a hypnotic.

### Indication

For short-term and intermittent use in patients with recurring insomnia and poor sleeping habits

### Pharmacodynamics

Flurazepam, a benzodiazepine derivative, is a hypnotic agent which does not appear to decrease dream time as measured by rapid eye movements (REM). Furthermore, it decreases sleep latency and number of awakenings for a consequent increase in total sleep time.

### Mechanism of Action

GABA(A) Receptor
Positive allosteric modulator
GABA(A) Receptor Benzodiazepine Binding Site
Ligand

### Absorption

Flurazepam hydrochloride is rapidly (30 minutes) absorbed from the gastrointestinal tract

### Metabolism

Flurazepam is rapidly metabolized and is excreted primarily in the urine. Both hydroxyethyl flurazepam (the major metabolite) and N-desalkyl flurazepam are active. The N-desalkyl metabolite is slowly excreted in the urine as the conjugated form
Hover over products below to view reaction partners
Flurazepam
Hydroxyethylflurazepam
Norflurazepam

### Half-life

The mean apparent half-life of flurazepam is 2.3 hours. The half life of elimination of N1-des-alkyl- flurazepam ranged from 47 to 100 hours

### Toxicity

Coma, confusion, low blood pressure, sleepiness

### Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

1,2-Benzodiazepine
The risk or severity of CNS depression can be increased when Flurazepam is combined with 1,2-Benzodiazepine.
Abacavir
Flurazepam may decrease the excretion rate of Abacavir which could result in a higher serum level.
Abametapir
The serum concentration of Flurazepam can be increased when it is combined with Abametapir.
Abatacept
The metabolism of Flurazepam can be increased when combined with Abatacept.
Aceclofenac
Aceclofenac may decrease the excretion rate of Flurazepam which could result in a higher serum level.

### Food Interactions

Avoid alcohol.
Take with or without food. The absorption is unaffected by food.

## Chemical Information

**DrugBank ID:** DB00690

**Synonyms:** Flurazepam
Flurazépam
Flurazepamum

**Chemical Formula:** C
21
H
23
ClFN
3
O

**SMILES:** CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F

**Weight:** Average: 387.878
Monoisotopic: 387.151368285

**IUPAC Name:** 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one

## Additional Information

### Modality

Small Molecule

### Patents

0

### Indicated Conditions

1

### Phase 0

0

### Phase 1

1

### Phase 2

0

### Phase 3

1

### Phase 4

0

### Therapeutic Categories

Benzodiazepines and benzodiazepine
derivatives

### Summary

Flurazepam
is a long-acting benzodiazepine with a rapid onset of action that is commonly used to treat insomnia.

### Brand Names

Dalmane

### Generic Name

Flurazepam

### DrugBank Accession Number

DB00690

### Groups

Approved, Illicit

### Structure

3D
Download
MOL
SDF
3D-SDF
PDB
SMILES
InChI
Similar Structures
Structure for Flurazepam (DB00690)
×
Close

### External IDs

ID 480
Ro 5-6901

### Associated Conditions

Indication Type
Indication
Combined Product Details
Approval Level
Age Group
Patient Characteristics
Dose Form
Treatment of
Insomnia
••••••••••••
Create Account
Create Account

### Mechanism of action

Flurazepam binds to an allosteric site on GABA-A receptors. Binding potentiates the action of GABA on GABA-A receptors by opening the chloride channel within the receptor, causing chloride influx and hyperpolarization.
Target
Actions
Organism
A
GABA(A) Receptor
positive allosteric modulator
Humans
A
GABA(A) Receptor Benzodiazepine Binding Site
ligand
Humans
U
Translocator protein
modulator
Humans

### Protein binding

83%

### Route of elimination

Flurazepam is rapidly metabolized and is excreted primarily in the urine. Less than 1% of the dose is excreted in the urine as N1-desalkyl-flurazepam.

### Product Ingredients

Ingredient
UNII
CAS
InChI Key
Flurazepam hydrochloride
7C4JH842IJ
36105-20-1
PUGVROXLRUQCAF-UHFFFAOYSA-N

### Product Images

Previous
Next

### International/Other Brands

Dalmadorm (Meda)
/
Dalmadorm medium (Meda)
/
Felison (SIT)
/
Flunox (Teofarma)
/
Insumin
/
Sompan (I.C.N.)
/
Valdorm (Valeas)

### Brand Name Prescription Products

Name
Dosage
Strength
Route
Labeller
Marketing Start
Marketing End
Region
Image
Dalmane
Capsule
15 mg
Oral
Valeant Canada Lp Valeant Canada S.E.C.
1971-12-31
2016-07-08
Canada
Dalmane
Capsule
30 mg
Oral
Valeant Canada Lp Valeant Canada S.E.C.
1971-12-31
2016-07-08
Canada
Flurazepam
Capsule
15 mg
Oral
Aa Pharma Inc
1982-12-31
Not applicable
Canada
Flurazepam
Capsule
30 mg
Oral
Aa Pharma Inc
1982-12-31
Not applicable
Canada
Flurazepam 15
Capsule
15 mg
Oral
Pro Doc Limitee
1982-12-31
2018-04-18
Canada

### Generic Prescription Products

Name
Dosage
Strength
Route
Labeller
Marketing Start
Marketing End
Region
Image
Bio-flurazepam
Capsule
15 mg
Oral
Biomed Pharma
2004-04-23
2022-07-19
Canada
Bio-flurazepam
Capsule
30 mg
Oral
Biomed Pharma
2004-04-23
2022-07-19
Canada
Flurazepam
Capsule
30 mg/1
Oral
Hikma Pharmaceuticals USA Inc.
1986-12-08
2015-01-18
US
Flurazepam
Capsule
30 mg/1
Oral
Golden State Medical Supply, Inc.
1986-12-08
2017-01-02
US
Flurazepam
Capsule
30 mg/1
Oral
Rebel Distributors
1986-12-08
Not applicable
US

### ATC Codes

N05CD01 — Flurazepam
N05CD — Benzodiazepine derivatives
N05C — HYPNOTICS AND SEDATIVES
N05 — PSYCHOLEPTICS
N — NERVOUS SYSTEM

### Drug Categories

Anti-Anxiety Agents
Benzazepines
Benzodiazepines and benzodiazepine derivatives
Benzodiazepinones
Central Nervous System Agents
Central Nervous System Depressants
Cytochrome P-450 CYP2A6 Substrates
Cytochrome P-450 CYP2E1 Inhibitors
Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)
Cytochrome P-450 CYP3A Substrates
Cytochrome P-450 CYP3A4 Substrates
Cytochrome P-450 Enzyme Inhibitors
Cytochrome P-450 Substrates
Drugs that are Mainly Renally Excreted
GABA Agents
GABA Modulators
Heterocyclic Compounds, Fused-Ring
Hypnotics and Sedatives
Nervous System
Neurotransmitter Agents
OCT2 Inhibitors
P-glycoprotein inhibitors
Psycholeptics
Psychotropic Drugs
Tranquilizing Agents

### Chemical TaxonomyProvided byClassyfire

Description
This compound belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Benzodiazepines
Sub Class
1,4-benzodiazepines
Direct Parent
1,4-benzodiazepines
Alternative Parents
Alpha amino acids and derivatives
/
Fluorobenzenes
/
Aryl chlorides
/
Aryl fluorides
/
Tertiary carboxylic acid amides
/
Trialkylamines
/
Lactams
/
Ketimines
/
Propargyl-type 1,3-dipolar organic compounds
/
Azacyclic compounds
/
Hydrocarbon derivatives
/
Carbonyl compounds
/
Organic oxides
/
Organochlorides
/
Organofluorides
/
Organopnictogen compounds
show 6 more
Substituents
1,4-benzodiazepine
/
Alpha-amino acid or derivatives
/
Amine
/
Amino acid or derivatives
/
Aromatic heteropolycyclic compound
/
Aryl chloride
/
Aryl fluoride
/
Aryl halide
/
Azacycle
/
Benzenoid
/
Carbonyl group
/
Carboxamide group
/
Carboxylic acid derivative
/
Fluorobenzene
/
Halobenzene
/
Hydrocarbon derivative
/
Imine
/
Ketimine
/
Lactam
/
Monocyclic benzene moiety
/
Organic 1,3-dipolar compound
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxygen compound
/
Organochloride
/
Organofluoride
/
Organohalogen compound
/
Organonitrogen compound
/
Organooxygen compound
/
Organopnictogen compound
/
Propargyl-type 1,3-dipolar organic compound
/
Tertiary aliphatic amine
/
Tertiary amine
/
Tertiary carboxylic acid amide
show 24 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available

### Kingdom

Organic compounds

### Super Class

Organoheterocyclic compounds

### Class

Benzodiazepines

### Sub Class

1,4-benzodiazepines

### Direct Parent

1,4-benzodiazepines

### Alternative Parents

Alpha amino acids and derivatives
/
Fluorobenzenes
/
Aryl chlorides
/
Aryl fluorides
/
Tertiary carboxylic acid amides
/
Trialkylamines
/
Lactams
/
Ketimines
/
Propargyl-type 1,3-dipolar organic compounds
/
Azacyclic compounds
/
Hydrocarbon derivatives
/
Carbonyl compounds
/
Organic oxides
/
Organochlorides
/
Organofluorides
/
Organopnictogen compounds
show 6 more

### Substituents

1,4-benzodiazepine
/
Alpha-amino acid or derivatives
/
Amine
/
Amino acid or derivatives
/
Aromatic heteropolycyclic compound
/
Aryl chloride
/
Aryl fluoride
/
Aryl halide
/
Azacycle
/
Benzenoid
/
Carbonyl group
/
Carboxamide group
/
Carboxylic acid derivative
/
Fluorobenzene
/
Halobenzene
/
Hydrocarbon derivative
/
Imine
/
Ketimine
/
Lactam
/
Monocyclic benzene moiety
/
Organic 1,3-dipolar compound
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxygen compound
/
Organochloride
/
Organofluoride
/
Organohalogen compound
/
Organonitrogen compound
/
Organooxygen compound
/
Organopnictogen compound
/
Propargyl-type 1,3-dipolar organic compound
/
Tertiary aliphatic amine
/
Tertiary amine
/
Tertiary carboxylic acid amide
show 24 more

### Molecular Framework

Aromatic heteropolycyclic compounds

### Affected organisms

Humans and other mammals

### UNII

IHP475989U

### CAS number

17617-23-1

### InChI Key

SAADBVWGJQAEFS-UHFFFAOYSA-N

### InChI

InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3

### Synthesis Reference

Fryer, R. and Sternbach, L.H.; U.S. Patent 3,567,710; March 2, 1971; assigned to Hoffman-La Roche, Inc.

### General References

Rickels K: The clinical use of hypnotics: indications for use and the need for a variety of hypnotics. Acta Psychiatr Scand Suppl. 1986;332:132-41. [
Article
]
Vermeeren A: Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs. 2004;18(5):297-328. [
Article
]
Oelschlager H: [Chemical and pharmacologic aspects of benzodiazepines]. Schweiz Rundsch Med Prax. 1989 Jul 4;78(27-28):766-72. [
Article
]
Rooke KC: The use of flurazepam (dalmane) as a substitute for barbiturates and methaqualone/diphenhydramine (mandrax) in general practice. J Int Med Res. 1976;4(5):355-9. [
Article
]
Olive G, Dreux C: [Pharmacologic bases of use of benzodiazepines in pereinatal medicine]. Arch Fr Pediatr. 1977 Jan;34(1):74-89. [
Article
]
Link [
Link
]

### External Links

Human Metabolome Database
HMDB0014828
KEGG Drug
D00329
PubChem Compound
3393
PubChem Substance
46508451
ChemSpider
3276
RxNav
4501
ChEBI
5128
ChEMBL
CHEMBL968
ZINC
ZINC000000537752
Therapeutic Targets Database
DAP000242
PharmGKB
PA449681
PDBe Ligand
FL7
RxList
RxList Drug Page
Drugs.com
Drugs.com Drug Page
PDRhealth
PDRhealth Drug Page
Wikipedia
Flurazepam

### Human Metabolome Database

HMDB0014828

### KEGG Drug

D00329

### PubChem Compound

3393

### PubChem Substance

46508451

### ChemSpider

3276

### RxNav

4501

### ChEBI

5128

### ChEMBL

CHEMBL968

### ZINC

ZINC000000537752

### Therapeutic Targets Database

DAP000242

### PharmGKB

PA449681

### PDBe Ligand

FL7

### RxList

RxList Drug Page

### Drugs.com

Drugs.com Drug Page

### PDRhealth

PDRhealth Drug Page

### Wikipedia

Flurazepam

### PDB Entries

2yoe

### MSDS

Download
(50.5 KB)

### Manufacturers

Valeant pharmaceuticals international
Halsey drug co inc
Mutual pharmaceutical co inc
Mylan pharmaceuticals inc
Par pharmaceutical inc
Purepac pharmaceutical co
Sandoz inc
Superpharm corp
Usl pharma inc
Warner chilcott inc
Warner chilcott div warner lambert co
Watson laboratories inc
West ward pharmaceutical corp

### Packagers

Amerisource Health Services Corp.
A-S Medication Solutions LLC
Bryant Ranch Prepack
Corepharma LLC
Direct Dispensing Inc.
Dispensing Solutions
Diversified Healthcare Services Inc.
H.J. Harkins Co. Inc.
Hl Moore Drug Exchange
Kaiser Foundation Hospital
Lake Erie Medical and Surgical Supply
Legacy Pharmaceuticals Packaging LLC
Major Pharmaceuticals
Mylan
Nucare Pharmaceuticals Inc.
Par Pharmaceuticals
PCA LLC
PD-Rx Pharmaceuticals Inc.
Physicians Total Care Inc.
Prepackage Specialists
Prepak Systems Inc.
Rebel Distributors Corp.
Remedy Repack
Southwood Pharmaceuticals
UDL Laboratories
Valeant Ltd.
West-Ward Pharmaceuticals

### Dosage Forms

Form
Route
Strength
Tablet, film coated
Oral
30 mg/1
Capsule
Oral
Capsule
Oral
15 mg/1
Capsule
Oral
30 mg
Capsule
Oral
30 mg/1
Capsule
Oral
15 mg
Tablet
Oral
27.42 mg
Capsule
Oral
15 mg / cap
Capsule
Oral
30 mg / cap
Tablet
Oral
15 mg
Tablet
Oral
30 mg

### Prices

Unit description
Cost
Unit
Dalmane 30 mg capsule
2.01USD
capsule
Dalmane 15 mg capsule
1.79USD
capsule
Flurazepam HCl 15 mg capsule
0.43USD
capsule
Flurazepam HCl 30 mg capsule
0.4USD
capsule
Flurazepam 30 mg capsule
0.34USD
capsule
Flurazepam 15 mg capsule
0.28USD
capsule
Apo-Flurazepam 30 mg Capsule
0.1USD
capsule
Apo-Flurazepam 15 mg Capsule
0.08USD
capsule
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.

### State

Solid

### Experimental Properties

Property
Value
Source
melting point (°C)
190-220
British Patent 1,040,548.
water solubility
500 mg/mL (HCl salt)
Not Available
logP
3.8
Not Available

### Predicted Properties

Property
Value
Source
Water Solubility
0.01 mg/mL
ALOGPS
logP
3.81
ALOGPS
logP
3.95
Chemaxon
logS
-4.6
ALOGPS
pKa (Strongest Basic)
8.71
Chemaxon
Physiological Charge
1
Chemaxon
Hydrogen Acceptor Count
3
Chemaxon
Hydrogen Donor Count
0
Chemaxon
Polar Surface Area
35.91 Å
2
Chemaxon
Rotatable Bond Count
6
Chemaxon
Refractivity
107.54 m
3
·mol
-1
Chemaxon
Polarizability
41.2 Å
3
Chemaxon
Number of Rings
3
Chemaxon
Bioavailability
1
Chemaxon
Rule of Five
Yes
Chemaxon
Ghose Filter
Yes
Chemaxon
Veber's Rule
Yes
Chemaxon
MDDR-like Rule
Yes
Chemaxon

### Predicted ADMET Features

Property
Value
Probability
Human Intestinal Absorption
+
1.0
Blood Brain Barrier
+
0.9898
Caco-2 permeable
+
0.6115
P-glycoprotein substrate
Substrate
0.8553
P-glycoprotein inhibitor I
Inhibitor
0.9455
P-glycoprotein inhibitor II
Inhibitor
0.6624
Renal organic cation transporter
Inhibitor
0.6523
CYP450 2C9 substrate
Non-substrate
0.7716
CYP450 2D6 substrate
Non-substrate
0.9116
CYP450 3A4 substrate
Substrate
0.7794
CYP450 1A2 substrate
Inhibitor
0.5194
CYP450 2C9 inhibitor
Non-inhibitor
0.7112
CYP450 2D6 inhibitor
Non-inhibitor
0.5469
CYP450 2C19 inhibitor
Inhibitor
0.5082
CYP450 3A4 inhibitor
Inhibitor
0.6347
CYP450 inhibitory promiscuity
High CYP Inhibitory Promiscuity
0.6231
Ames test
Non AMES toxic
0.9132
Carcinogenicity
Non-carcinogens
0.7597
Biodegradation
Not ready biodegradable
1.0
Rat acute toxicity
2.5654 LD50, mol/kg
Not applicable
hERG inhibition (predictor I)
Weak inhibitor
0.9528
hERG inhibition (predictor II)
Inhibitor
0.7183
ADMET data is predicted using
admetSAR
, a free tool for evaluating chemical ADMET properties. (
23092397
)

### Spectra

Spectrum
Spectrum Type
Splash Key
Predicted GC-MS Spectrum - GC-MS
Predicted GC-MS
splash10-059i-9025000000-1b62ce2349d2235158ef
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-000i-0009000000-c0e65a54e856d501ed8c
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-014r-0009000000-5a2839fdce5817956437
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-014i-0009000000-ef2f40465f355c7e04c0
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-014i-0049000000-aeef40f08b145e9212fb
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-014i-0392000000-706f2398b20890152e43
Predicted MS/MS Spectrum - 10V, Positive (Annotated)
Predicted LC-MS/MS
splash10-000i-6009000000-3af7bf0ed7d2bd72edbb
Predicted MS/MS Spectrum - 10V, Negative (Annotated)
Predicted LC-MS/MS
splash10-014i-0029000000-8f7bd2b23d4250687f5b
Predicted MS/MS Spectrum - 20V, Positive (Annotated)
Predicted LC-MS/MS
splash10-014i-0009000000-9ff5e663eee4ad861964
Predicted MS/MS Spectrum - 20V, Negative (Annotated)
Predicted LC-MS/MS
splash10-000l-4039000000-abde750310aa2f73fdfb
Predicted MS/MS Spectrum - 40V, Positive (Annotated)
Predicted LC-MS/MS
splash10-00r2-0094000000-48da74d5453994ff3848
Predicted MS/MS Spectrum - 40V, Negative (Annotated)
Predicted LC-MS/MS
splash10-00lr-7394000000-754f9f0079e47adc24e8
Predicted 1H NMR Spectrum
1D NMR
Not Applicable
Predicted 13C NMR Spectrum
1D NMR
Not Applicable

### Chromatographic Properties

Collision Cross Sections (CCS)
Adduct
CCS Value (Å
2
)
Source type
Source
[M-H]-
194.2482869
predicted
DarkChem Lite v0.1.0
[M-H]-
189.62123
predicted
DeepCCS 1.0 (2019)
[M+H]+
194.5635869
predicted
DarkChem Lite v0.1.0
[M+H]+
192.05421
predicted
DeepCCS 1.0 (2019)
[M+Na]+
194.3718869
predicted
DarkChem Lite v0.1.0
[M+Na]+
199.52672
predicted
DeepCCS 1.0 (2019)

### Kind

Protein

### Organism

Humans

### Pharmacological action

Unknown

### Actions

Inhibitor

### Curator comments

Benzodiazepines modulate GABA(A) function by binding at the interface between alpha (α) and gamma (γ) subunits. Of the 6 α-subunits, only 4 (α-1, -2, -3, and -5) participate in the formation of this binding site. The above target is a collection of all α- and γ-subunits that are known to participate in the formation of the benzodiazepine binding site.

### General Function

Electrogenic voltage-dependent transporter that mediates the transport of a variety of organic cations such as endogenous bioactive amines, cationic drugs and xenobiotics (PubMed:9260930, PubMed:9687576). Functions as a Na(+)-independent, bidirectional uniporter (PubMed:21128598, PubMed:9687576). Cation cellular uptake or release is driven by the electrochemical potential, i.e. membrane potential and concentration gradient (PubMed:15212162, PubMed:9260930, PubMed:9687576). However, may also engage electroneutral cation exchange when saturating concentrations of cation substrates are reached (By similarity). Predominantly expressed at the basolateral membrane of hepatocytes and proximal tubules and involved in the uptake and disposition of cationic compounds by hepatic and renal clearance from the blood flow (PubMed:15783073). Implicated in monoamine neurotransmitters uptake such as histamine, dopamine, adrenaline/epinephrine, noradrenaline/norepinephrine, serotonin and tyramine, thereby supporting a physiological role in the central nervous system by regulating interstitial concentrations of neurotransmitters (PubMed:16581093, PubMed:17460754, PubMed:9687576). Also capable of transporting dopaminergic neuromodulators cyclo(his-pro), salsolinol and N-methyl-salsolinol, thereby involved in the maintenance of dopaminergic cell integrity in the central nervous system (PubMed:17460754). Mediates the bidirectional transport of acetylcholine (ACh) at the apical membrane of ciliated cell in airway epithelium, thereby playing a role in luminal release of ACh from bronchial epithelium (PubMed:15817714). Also transports guanidine and endogenous monoamines such as vitamin B1/thiamine, creatinine and N-1-methylnicotinamide (NMN) (PubMed:12089365, PubMed:15212162, PubMed:17072098, PubMed:24961373, PubMed:9260930). Mediates the uptake and efflux of quaternary ammonium compound choline (PubMed:9260930). Mediates the bidirectional transport of polyamine agmatine and the uptake of polyamines putrescine and spermidine (PubMed:12538837, PubMed:21128598). Able to transport non-amine endogenous compounds such as prostaglandin E2 (PGE2) and prostaglandin F2-alpha (PGF2-alpha) (PubMed:11907186). Also involved in the uptake of xenobiotic 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP) (PubMed:12395288, PubMed:16394027). May contribute to regulate the transport of organic compounds in testis across the blood-testis-barrier (Probable)

### Specific Function

acetylcholine transmembrane transporter activity

### Gene Name

SLC22A2

### Uniprot ID

O15244

### Uniprot Name

Solute carrier family 22 member 2

### Molecular Weight

62579.99 Da

